Production and SERS characterization of bacteriocin-like inhibitory substances by latilactobacillus sakei in whey permeate powder: exploring natural antibacterial potential.

Camila Ramão Contessa, Eduardo Ceretta Moreira, Caroline Costa Moraes, Janaína Fernandes de Medeiros Burkert

Abstract read

In one paragraph

Article in Bioprocess and biosystems engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Camila Ramão ContessaEngineering and Science of Food Graduate Program, College of Chemistry and Food Engineering, Laboratory Bioprocess Engineering, Federal University of Rio Grande, PO Box 474, Rio Grande, RS, 96203-900, Brazil. camilaramao@hotmail.com.

Eduardo Ceretta MoreiraScience and Engineering of Materials Graduate Program, Spectroscopy Laboratory, Federal University of Pampa, PO Box 1650, Bagé, RS, 96413170, Brazil.

Caroline Costa MoraesScience and Engineering of Materials Graduate Program, Laboratory of Microbiology and Food Toxicology, Federal University of Pampa, PO Box 1650, Bagé, RS, 96413170, Brazil.

Janaína Fernandes de Medeiros BurkertEngineering and Science of Food Graduate Program, College of Chemistry and Food Engineering, Laboratory Bioprocess Engineering, Federal University of Rio Grande, PO Box 474, Rio Grande, RS, 96203-900, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriocins are antimicrobial compounds that have awakened interest across several industries due to their effectiveness. However, their large-scale production often becomes unfeasible on an industrial scale, primarily because of high process costs. Addressing this challenge, this work analyzes the potential of using low-cost whey permeate powder, without any supplementation, to produce bacteriocin-like inhibitory substances (BLIS) through the fermentation of Latilactobacillus sakei. For this purpose, different concentrations of whey permeate powder (55.15 gL

Indexed as

Anti-Bacterial AgentsBacteriocinsLatilactobacillus sakeiSpectrum Analysis, RamanWheyFermentationPowdersAnti-Bacterial AgentsBacteriocinsPowdersBioactiveCost-effective productionLatilactobacillus sakeiRaman spectroscopy

Identifiers

PMID39014172

DOI10.1016/j.mimet.2011.11.008

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.